However, numerous other studies indicated lower expression of SESN2 in several cancers, including hepatocellular carcinoma, non-small cell lung cancer, bladder cancer, and colon cancer tissues than that in non-cancerous tissues [27,28,29,30]. This evidence concerns the gene SESN2 and cancer.